5Parkin D M, Bray F, Ferlay J, et al. Estimating the world cancer burden: globoean 2000[J]. Int J Cancer, 2001,94(2):153- 156.
6Guilbert J J. The world health report 2002 reducing risks, prorooting healthy life[J]. Educ Health ( Abingdon), 2003,16 ( 2 ) : 230.
7Rosell R, Lord R V, Taron M, et al. DNA repair and cisplatin resistance in non-small cell lung cancer[J]. Lung Cancer, 2002, 38(3) :217-227.
8Su D, Ma S, Liu P, et al. Genetic polymorphisms and treatment response in advanced non-small cell lung cancer[J]. Lung Cancer,2007, 56(2) :281-288.
9Yin J, Vogel U, Ma Y, et al. A haplotype encompassing the variant allele of DNA repair gene polymorphism ERCC2/XPD Lys751Gln hut not the variant allele of Asp312Asn is associated with risk of lung cancer in a northeastern Chinese population[J]. Cancer Genetics Cytogenetics, 2007,175(1) :47-51.
10Park J Y, Park S H, Choi J E, et al. Polymorphisms of the DNA repair gene xeroderma pigmentosum group A and risk of primary lung cancer [J]. Cancer Epidemiol Biomarkers Prey, 2002,11(10 Pt 1):993-997.
